Showing results (371-380 of 452) with videos related to
Sort By:
Pageof 46
Frontiers in Neurology|July 7, 2020
Peripapillary Vessel Density as Early Biomarker in Multiple SclerosisGilda Cennamo, Antonio Carotenuto, Daniela Montorio, et al.Annals of Neurology|April 3, 2024
Determinants and Biomarkers of Progression Independent of Relapses in Multiple SclerosisMassimiliano Calabrese, Paolo Preziosa, Antonio Scalfari, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 15, 2021
Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS AllianceKathleen M Zackowski, Jennifer Freeman, Giampaolo Brichetto, et al.Journal of Neurology|May 21, 2026
Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx studyFrancesco Romanò, Paola Valsasina, Matteo Albergoni, et al.Neurorehabilitation and Neural Repair|March 1, 2024
Prevalence and Associated Clinical Characteristics of Walking-Related Motor, Cognitive, and Fatigability in Progressive Multiple Sclerosis: Baseline Results From the CogEx StudyCintia Ramari, Mieke D'hooge, Ulrik Dalgas, et al.Journal of Clinical Medicine|September 9, 2022
Quality of Life Changes in Early-Onset Multiple Sclerosis: A 4-Year Follow-Up StudyLaura Rosa, Maria Petracca, Antonio Carotenuto, et al.European Journal of Neurology|May 2, 2025
Identifying neuropsychological phenotypes in multiple sclerosis using latent profile analysisAntonio Luca Spiezia, Giuseppe Pontillo, Fabrizia Falco, et al.Journal of Neurology|November 27, 2022
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosisPaolo Preziosa, Maria A Rocca, Elisabetta Pagani, et al.Journal of the Neurological Sciences|December 7, 2025
Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosisValerio Nicolella, Marco Varelli, Stefania Fasano, et al.Neurology(R) Neuroimmunology & Neuroinflammation|March 7, 2020
Impact of treatment on cellular immunophenotype in MS: A cross-sectional studyMaria Cellerino, Federico Ivaldi, Matteo Pardini, et al.Pageof 46